Search results
You searched for:
Found 246 results
Sorting options:
Date: 01/01/2026 Location: Other
Neuroendocrine tumours (NETs) are a heterogeneous group of neoplastic lesions that arise in the neuroendocrine system, and at many different disease sites. Once considered a rare disease, NET incidence has increased in recent decades. Depending on the body
5 Educational activity hours
Date: 01/01/2026 Location: Other
This activity has been designed to enable GPs to identify, manage and support patients with liver disease. As liver disease affects up to 3 of every 10 Australian adults and primary liver cancer is the most rapidly rising cause of cancer death, GPs must be
5 Educational activity hours
2 Performance review hours
Date: 01/01/2026 Location: Other
Erectile dysfunction (ED) is a common condition affecting ~20% of Australian men aged andgt;40 years.Despite having significant impacts on quality of life, ED often goes undetected and undertreated.Many men may feel reluctant to bring ED up themselves, so by
1 Educational activity hour
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
For years, type 2 diabetes management in Australia has centred around treating to glycaemic targets, particularly HbA1c - a reactive approach that often waited for failure before adjusting treatment. But the paradigm has shifted with recent changes to the PBS.
1 Educational activity hour
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
Five years on from the start of COVID-19, the acute phase of the pandemic has passed but variants continue to circulate with periodic increases in transmission. For GPs and their patients, staying informed and proactive is crucial, especially for vulnerable
1.5 Educational activity hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
In this on-demand webinar we explore the new era in opioid dependence treatment and unpack the implications of these transformative changes, highlighting how they democratise access to treatments, including Long-Acting Injectable Buprenorphine (LAIB). While
1 Educational activity hour
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of mortality and morbidity in Australia. Low density lipoprotein cholesterol (LDL-C) is a key causal factor in this pathological process and the primary target in the secondary prevention of
1.5 Educational activity hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
Vaccination is one of the safest and most effective healthcare measures, and adult vaccines reduce the risk of severe disease, hospitalisation, and death. Yet, while Australia leads the world in paediatric immunisation rates, adult vaccination coverage
1 Educational activity hour
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
Patients with clinically established atherosclerotic cardiovascular disease (ASCVD) are at very high risk of recurrent major adverse cardiovascular events (MACE). Recently, The European Society of Cardiology published a clinical consensus statement on obesity
1.5 Educational activity hours
1 Performance review hour
1 Outcome measurement hour
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This program includes five (5) sections providing an overview of:Introduction to ARF and RHD (an overview)Physiology of RHDSecondary prophylaxisInjection sitesManaging injection pain and distress.The purpose of this program is to empower front-line clinical
1 Educational activity hour
Culturally safe practice
Professionalism
Ethical practice
Addressing health inequities